首页 | 本学科首页   官方微博 | 高级检索  
检索        

Bcl-2shRNA表达载体的构建及其对HL-60细胞生长的抑制作用
引用本文:何冬梅,张洹,刘革修,邹飞雁.Bcl-2shRNA表达载体的构建及其对HL-60细胞生长的抑制作用[J].中国现代医学杂志,2005,15(24):3736-3739,3742.
作者姓名:何冬梅  张洹  刘革修  邹飞雁
作者单位:1. 暨南大学,医学院血液病研究所,广东,广州,510632
2. 暨南大学,生命科学技术学院生殖免疫研究所,广东,广州,510632
基金项目:本文课题受广东省自然科学重点基金(编号:021195)及和广东省自然科学基金(编号:04010446)资助
摘    要:目的构建Bcl-2短发夹样RNA(short hairpin RNA,shRNA)序列的表达载体并研究其对HL-60细胞生长的抑制作用。方法化学合成2段编码短发夹RNA序列针对Bcl-2基因66个碱基的寡核苷酸,克隆到Pgenesil-1载体的u6启动子的下游,重组构建RNAi质粒,同时设立阴性对照;然后经酶切电泳和DNA测序鉴定。采用脂质体介导的转染方法将重组的RNAi质粒转入HL-60细胞后,采用RT-PCR检测Bcl-2mRNA表达水平;采用MTT法测定细胞增殖情况。结果重组构建的两个Bcl-2 shRNA1、shRNA2载体经双酶切电泳分析及插入基因片段序列分析,结果表明66个碱基成功插入到预期位点,并且序列完全一致。转染Bcl-2 shRNA1、shRNA2载体分别入HL-60细胞24h,其Bcl-2 mRNA表达水平均降低,但转染Bcl-2 shRNA1引起的Bcl-2 mRNA表达下降更为明显,分别与转染阴性shKNA及未转染组比较,有显著性差异(P〈0.05)。MTT测定显示转染Bcl-2 shRNA1、shRNA2载体入HL-60细胞在72、96h细胞生长明显受到抑制,分别与转染阴性shRNA、单纯脂质体组及未转染组比较,差异有显著性(P〈0.05)。结论成功地构建了两个Bcl-2 shRNA1、shRNA2表达载体,且Bcl-2 shRNA可序列特异性地抑制HL-60细胞的生长。

关 键 词:Bcl-2  shR  NA  RNAi  HL-60细胞
文章编号:1005-8982(2005)24-3736-04
收稿时间:2005-01-27
修稿时间:2005-01-27

Construction of Bcl-2 shRNA expression plasmid and its inhibition on the growth of HL-60 cells
HE Dong-mei,ZHANG Yuan,LIU Ge-xiu,ZOU Fei-yan.Construction of Bcl-2 shRNA expression plasmid and its inhibition on the growth of HL-60 cells[J].China Journal of Modern Medicine,2005,15(24):3736-3739,3742.
Authors:HE Dong-mei  ZHANG Yuan  LIU Ge-xiu  ZOU Fei-yan
Institution:1.Institute of Hematology, Medical College of Jinan University,; 2.Research Institute of Reproductive Immunology, College of Life and Science Technology, Jinan University Guangzhou, Guangdong 510632, P.R. China
Abstract:Objective] To construct expressing vector of short hairpin RNA( shRNA ) targeting Bcl-2,and investigate the effects of Bcl-2 shRNA on the growth of HL-60 cell line. Methods] Two of 66 base pairs oligonucleotides for short hairpin expression targeting the coding region of Bcl-2 mRNA were designed and were chemically synthesized. Double DNA sequences were obtained through annealing. Pgenesil-1 vector was linearized with BamHI and HindIII. Finally, annealed oligonucleotides were inserted into the downstream of treated Pgenesil-1 vector U6 promoter to construct RNAi plasmid. Oligonucleotide with a scrambled sequence was used as negative control. Recombinant expression vector was identified by digestion with PstI and SalI and confirmed by sequencing analysis. Bcl-2 shRNAs were transfected into HL-60 with Lipofectamine. Cytotoxic effects were measured by use of MTT method. The expression levels of Bcl-2 mRNA were assayed by RT-PCR. Results] Identifying by enzyme cutting and sequencing showed the insertion sequence was correct. Furthermore, 66 bp had been inserted the expected site. RT-PCR assay showed that the expression levels of Bcl-2 mRNA from HL-60 cells decreased after Bcl-2 shRNAs treatment. There was no difference in Bcl-2 mRNA levels between control shRNA and untreated cells. Viable cells at 48, 72 and 96 h after treatment with Bcl-2 shRNAs were less than that after treatment with control shRNAs and untreated HL-60 cells, respectively (P <0.05). Conclusion] Bcl-2 shRNA expression vectors have been constructed successfully, could effectively inhibit the growth of HL-60 cells.
Keywords:Bcl-2  shRNA  RNAi  HL-60 cells
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号